Trust score 8/100
Masoud Haji
Urologe Medikamentose Tumortherapie Palliativmediziner · bremen
👤 2 years of experience
12,553+
Patients seen
2
Years in practice
5
Publications
0
Languages spoken
About
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Masoud Haji
Education & training
-
2016–2022 MD · Medicine and Surgery
-
2022–2026 Residency · Urologe Medikamentose Tumortherapie Palliativmediziner
-
2026–2027 Fellowship · Subspecialty training
Career & appointments
-
2026-09–2027-08 Junior consultant
Licenses & insurance
Medical licenses
DE — Bundesärztekammer
Board certifications
European Board of Urologe Medikamentose Tumortherapie Palliativmediziner
Malpractice insurance:
HDI Global · 5,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 3,028 |
| Annual physical exam | 99395 | 1,170 |
| Vaccination administration | 90471 | 1,266 |
| Minor procedure (skin) | 17110 | 1,405 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 720.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 630.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 6 · i10: 6
-
European registry analysis of Urologe Medikamentose Tumortherapie Palliativmediziner outcomes
DOI: 10.3320/euroclin.2025.0 · PMID: 38674469 · cited by 148
-
Outcomes of Urologe Medikamentose Tumortherapie Palliativmediziner in adults — a multi-centre cohort
DOI: 10.5601/euroclin.2024.1 · PMID: 38353957 · cited by 30
-
European registry analysis of Urologe Medikamentose Tumortherapie Palliativmediziner outcomes
DOI: 10.5289/euroclin.2023.2 · PMID: 32799214 · cited by 40
-
Outcomes of Urologe Medikamentose Tumortherapie Palliativmediziner in adults — a multi-centre cohort
DOI: 10.2942/euroclin.2022.3 · PMID: 39680543 · cited by 114
Invited talks
- Practical updates in Urologe Medikamentose Tumortherapie Palliativmediziner European Annual Congress (Urologe Medikamentose Tumortherapie Palliativmediziner) · Vienna · 2024 · invited
- Single-centre experience in Urologe Medikamentose Tumortherapie Palliativmediziner National Society Meeting · bremen · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Urologe Medikamentose Tumortherapie Palliativmediziner — bremen · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2027
- national college of family doctors — Member · Since 2027
- European Union of Medical Specialists (UEMS) — Member · Since 2027
Articles by this doctor
- Patient education Patient guide to Urologe Medikamentose Tumortherapie Palliativmediziner
- Awareness When should you see a urologe medikamentose tumortherapie palliativmediziner?
For international patients
- Coordinator
- Patient liaison · jameda.masoud.haji@euroclinics.example
Location
1 tagPatient reviews
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.